Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel

PURPOSE: Obese patients exhibit an overall increased platelet reactivity and a reduced sensitivity to antiplatelet therapy. The aim of this study is to evaluate the platelet reactivity measured by impedance aggregometry in overweight and obese patients and chronic coronary syndrome (CCS) that were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Puccini, Marianna, Rauch, Christian, Jakobs, Kai, Friebel, Julian, Hassanein, Adel, Landmesser, Ulf, Rauch, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397124/
https://www.ncbi.nlm.nih.gov/pubmed/35211819
http://dx.doi.org/10.1007/s10557-022-07325-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397124/
https://www.ncbi.nlm.nih.gov/pubmed/35211819
http://dx.doi.org/10.1007/s10557-022-07325-z

Ejemplares similares